Search research articles
Contact Us
Filters
Showing results (51-60 of 61) with videos related to
Page
of 7
Sort By:
International Angiology : a Journal of the International Union of Angiology
|
December 19, 2014
Pycnogenol® and Centella asiatica in the management of asymptomatic atherosclerosis progression
G Belcaro, E Ippolito, M Dugall, et al.
Panminerva Medica
|
November 24, 2011
Prevention of post thrombotic syndrome with Pycnogenol® in a twelve month study
B M Errichi, G Belcaro, M Hosoi, et al.
European Review for Medical and Pharmacological Sciences
|
January 31, 2015
Cranberry supplementation in the prevention of non-severe lower urinary tract infections: a pilot study
A Ledda, A Bottari, R Luzzi, et al.
The International Journal of Angiology : Official Publication of the International College of Angiology, Inc
|
August 15, 2017
Management of Varicose Veins and Chronic Venous Insufficiency in a Comparative Registry with Nine Venoactive Products in Comparison with Stockings
G Belcaro, M Dugall, R Luzzi, et al.
Panminerva Medica
|
December 25, 2010
Prevention of flu episodes with colostrum and Bifivir compared with vaccination: an epidemiological, registry study
G Belcaro, M R Cesarone, U Cornelli, et al.
Panminerva Medica
|
November 24, 2011
Venoruton®: post thrombotic syndrome. Clinical improvement in venous insufficiency (signs and symptoms) with Venoruton®. A five-year, open-registry, efficacy study
E Ippolito, G Belcaro, M Dugall, et al.
Panminerva Medica
|
December 18, 2012
Meriva®, a lecithinized curcumin delivery system, in diabetic microangiopathy and retinopathy
R Steigerwalt, M Nebbioso, G Appendino, et al.
Panminerva Medica
|
November 24, 2011
Pycnogenol® improvements in asthma management
G Belcaro, R Luzzi, P Cesinaro Di Rocco, et al.
Panminerva Medica
|
November 24, 2011
Osteoporosis of the jaw. Product evaluation: mf Odontovis Calcium®
R Luzzi, G Belcaro, U Cornelli, et al.
Minerva Cardioangiologica
|
August 4, 2012
[Severe intermittent claudication: PGE1 treatment. A 40-week registry, efficacy and costs]
R Luzzi, G Belcaro, E Ippolito, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 61) with videos related to
Sort By:
Page
of 7
International Angiology : a Journal of the International Union of Angiology
|
December 19, 2014
Pycnogenol® and Centella asiatica in the management of asymptomatic atherosclerosis progression
G Belcaro, E Ippolito, M Dugall, et al.
Panminerva Medica
|
November 24, 2011
Prevention of post thrombotic syndrome with Pycnogenol® in a twelve month study
B M Errichi, G Belcaro, M Hosoi, et al.
European Review for Medical and Pharmacological Sciences
|
January 31, 2015
Cranberry supplementation in the prevention of non-severe lower urinary tract infections: a pilot study
A Ledda, A Bottari, R Luzzi, et al.
The International Journal of Angiology : Official Publication of the International College of Angiology, Inc
|
August 15, 2017
Management of Varicose Veins and Chronic Venous Insufficiency in a Comparative Registry with Nine Venoactive Products in Comparison with Stockings
G Belcaro, M Dugall, R Luzzi, et al.
Panminerva Medica
|
December 25, 2010
Prevention of flu episodes with colostrum and Bifivir compared with vaccination: an epidemiological, registry study
G Belcaro, M R Cesarone, U Cornelli, et al.
Panminerva Medica
|
November 24, 2011
Venoruton®: post thrombotic syndrome. Clinical improvement in venous insufficiency (signs and symptoms) with Venoruton®. A five-year, open-registry, efficacy study
E Ippolito, G Belcaro, M Dugall, et al.
Panminerva Medica
|
December 18, 2012
Meriva®, a lecithinized curcumin delivery system, in diabetic microangiopathy and retinopathy
R Steigerwalt, M Nebbioso, G Appendino, et al.
Panminerva Medica
|
November 24, 2011
Pycnogenol® improvements in asthma management
G Belcaro, R Luzzi, P Cesinaro Di Rocco, et al.
Panminerva Medica
|
November 24, 2011
Osteoporosis of the jaw. Product evaluation: mf Odontovis Calcium®
R Luzzi, G Belcaro, U Cornelli, et al.
Minerva Cardioangiologica
|
August 4, 2012
[Severe intermittent claudication: PGE1 treatment. A 40-week registry, efficacy and costs]
R Luzzi, G Belcaro, E Ippolito, et al.
Page
of 7